CNS & neurological disorders drug targets

Parkinson's Disease: Unravelling the Medicinal Perspectives and Recent Developments of Heterocyclic Monoamine Oxidase-B Inhibitors.

Pub Date : 2024-11-04 DOI: 10.2174/0118715273340983241018095529 Neha Rana, Parul Grover

Enhanced Neuroprotection in Experiment Multiple Sclerosis through Combined Rosiglitazone and Probiotic-Loaded Solid Lipid Nanoparticles: Modulation of Cellular Signaling Pathways.

Pub Date : 2024-11-01 DOI: 10.2174/0118715273336107241015100912 Nitish Kumar, Nidhi Tyagi, Sidharth Mehan, Alok Pratap Singh

Parkinson's Disease: A Progressive Neurodegenerative Disorder and Structure-Activity Relationship of MAO Inhibitor Scaffolds as an Important Therapeutic Regimen.

Pub Date : 2024-10-30 DOI: 10.2174/0118715273324300241010054029 Salauddin, Syed Amir Azam Zaidi, Mohammed Ubaid, Saniya Shamim, Mohd Javed Naim, Suruchi Khanna, Ozair Alam